All posts by: Michael Zand

About Michael Zand

Stem Cell Therapy Network’s Summer Workshops Help Physicians Build … – MarketWatch

Continue reading

2015-04-27 NEWS

Stem Cell Therapy Network’s Summer Workshops Help Physicians Build
MarketWatch
LITTLE ROCK, Ark., April 27, 2015 /PRNewswire/ — Demand for stem cell therapy and platelet-rich plasma (PRP) therapy is exploding, and for good reason: Regenerative medicine offers hope for patients with a myriad of injuries. As patients learn that

and more »

Continue reading

2015-04-27 NEWS

Science Daily

Stemcell-based therapy promising for treatment of breast cancer metastases in
Science Daily
Investigators from Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute have developed an imageable mouse model of brain-metastatic breast cancer and shown the potential of a stemcell-based therapy to eliminate metastatic cells …
Stem Cells Grow on Dead Feeder CellsGenetic Engineering & Biotechnology News
The Coming Of Age Of Stem Cell TechnologyHuffington Post India
Some stem cells heal differently, researchers saidThe Augusta Chronicle
Scicasts (press release) (blog) –Guardian Liberty Voice
all 8 news articles »
Continue reading

2015-04-26 NEWS

Athersys stem cells still show potential
Crain’s Cleveland Business
There, regulators have eased restrictions on stem cell therapies that have proven to be safe, and MultiStem hasn’t shown any safety issues. Plus, Athersys already has an ally in Japan who could help fund such a study: It struck a licensing agreement

Continue reading

2015-04-26 NEWS

Athersys stem cells still show potential
Crain’s Cleveland Business
There, regulators have eased restrictions on stem cell therapies that have proven to be safe, and MultiStem hasn’t shown any safety issues. Plus, Athersys already has an ally in Japan who could help fund such a study: It struck a licensing agreement

Continue reading

2015-04-26 NEWS

2 Minute Medicine

Autologous stemcell transplantation may be safe without transfusion support
2 Minute Medicine
1. In a prospective cohort study of over 120 Jehovah’s Witnesses with lymphoma and multiple myeloma, high-dose chemotherapy (HDC), and autologous stemcell transplantation (ASCT) without transfusion support was associated with relatively low mortality …